The Global Nasal Antihistamines Industry is experiencing a remarkable growth trajectory, set to achieve a valuation of approximately US$ 2.06 billion by 2023 and reaching a significant milestone of US$ 3.23 billion by 2033. This impressive expansion is fueled by a compound annual growth rate (CAGR) of 4.6%, highlighting the escalating demand for these crucial …